Healthcare providers can perform targeted assessment including thyroid function tests, cardiovascular evaluation, and review of concurrent medications that might contribute to vasomotor symptoms
Beyond Novo and Eli Lilly, companies such as Boehringer Ingelhium, Pfizer, Roche, AstraZeneca, Regor therapeutics, Viking Therapeutics, Amgen, BioAge Labs, Gan & Lee Pharmaceuticals, Sun Pharma, Innovent Biologics, Aphaia Pharma, Vertex Pharmaceuticals , and others are entering the space, fueling new innovations in GLP-1 therapies, combination therapies, and next-gen metabolic treatments
You can pinch it
This is where supplementation becomes particularly valuable
Ive been prescribing these medications for about two years now, and Ive learned more from my patients experiences than I ever did from the clinical trials